N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide
CAS : 251456-60-7
Ref. 3D-FH24290
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide
Synonymes :
- 4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
- Benzamide, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-
Description :
N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide is a hydroxamic acid that inhibits the activity of cyclin D2, which is required for cells to progress through the G1 phase of the cell cycle. This drug may also inhibit histone deacetylase and have an effect on epigenetic modulators. N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide has been shown to induce apoptosis in cancer cells, and can be used as a combination therapy with suberoylanilide hydroxamic acid or suberoylanilide. This drug may also act as a toll-like receptor 4 (TLR4) inhibitor.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
307.39 g/mol
Formule :
C16H25N3O3
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C16H25N3O3/c1-19(2)14-10-8-13(9-11-14)16(21)17-12-6-4-3-5-7-15(20)18-22/h8-11,22H,3-7,12H2,1-2H3,(H,17,21)(H,18,20)
Code InChI :
InChIKey=MXWDSZWTBOCWBK-UHFFFAOYSA-N
SMILES :
CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
